BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35213358)

  • 21. Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.
    Dai Z; Peng X; Guo Y; Shen X; Ding W; Fu J; Liang Z; Song J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2393-2416. PubMed ID: 35731273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
    Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
    Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.
    Liu J; Yi J; Zhang Z; Cao D; Li L; Yao Y
    Aging (Albany NY); 2021 Jun; 13(12):16513-16526. PubMed ID: 34157681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
    Chen F; Li Z; Deng C; Yan H
    J Transl Med; 2019 Aug; 17(1):299. PubMed ID: 31470869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
    Wang X; Duanmu J; Fu X; Li T; Jiang Q
    J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the transcriptomic features of microsatellite instability subtype colon cancer.
    Wang H; Wang X; Xu L; Zhang J; Cao H
    BMC Cancer; 2019 Jun; 19(1):605. PubMed ID: 31221124
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Li M; Ma Y; Zhong Y; Liu Q; Chen C; Qiang L; Wang X
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
    Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.
    Romero JM; Grünwald B; Jang GH; Bavi PP; Jhaveri A; Masoomian M; Fischer SE; Zhang A; Denroche RE; Lungu IM; De Luca A; Bartlett JMS; Xu J; Li N; Dhaliwal S; Liang SB; Chadwick D; Vyas F; Bronsert P; Khokha R; McGaha TL; Notta F; Ohashi PS; Done SJ; O'Kane GM; Wilson JM; Knox JJ; Connor A; Wang Y; Zogopoulos G; Gallinger S
    Clin Cancer Res; 2020 Apr; 26(8):1997-2010. PubMed ID: 31964786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
    Liu J; Liu F; Li X; Song X; Zhou L; Jie J
    Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
    Tanaka N; Sivanandham M; Wallack MK
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
    Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
    Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel prognostic model based on multi-omics features predicts the prognosis of colon cancer patients.
    Yang H; Jin W; Liu H; Wang X; Wu J; Gan D; Cui C; Han Y; Han C; Wang Z
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1255. PubMed ID: 32396280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune cell infiltration-associated signature in colon cancer and its prognostic implications.
    Deng D; Luo X; Zhang S; Xu Z
    Aging (Albany NY); 2021 Aug; 13(15):19696-19709. PubMed ID: 34349038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis.
    Zhu J; Kong W; Huang L; Bi S; Jiao X; Zhu S
    Front Immunol; 2023; 14():1142609. PubMed ID: 37020539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.